OTCPK:SNWV

Stock Analysis Report

Executive Summary

SANUWAVE Health, Inc., a shock wave technology company, focuses on the development and commercialization of noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States, Europe, Canada, Asia, and the Asia Pacific.

Snowflake

Fundamentals

Limited growth with worrying balance sheet.

Risks

  • SANUWAVE Health is covered by less than 3 analysts.

Similar Companies

Share Price & News

How has SANUWAVE Health's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-0.06%

SNWV

1.2%

US Medical Equipment

-0.6%

US Market


1 Year Return

-32.2%

SNWV

9.7%

US Medical Equipment

0.7%

US Market

SNWV underperformed the Medical Equipment industry which returned 9.9% over the past year.

SNWV underperformed the Market in United States of America which returned 0.7% over the past year.


Share holder returns

SNWVIndustryMarket
7 Day-0.06%1.2%-0.6%
30 Day14.7%3.5%4.9%
90 Day10.6%3.2%1.7%
1 Year-32.2%-32.2%10.6%9.7%3.0%0.7%
3 Year3.3%3.3%70.6%65.4%44.8%35.4%
5 Year-22.6%-22.6%139.4%112.2%62.0%44.3%

Price Volatility Vs. Market

How volatile is SANUWAVE Health's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is SANUWAVE Health undervalued based on future cash flows and its price relative to the stock market?


In this section, we usually try to help investors determine whether SANUWAVE Health is trading at an attractive price based on the cash flow it is expected to produce in the future. But as SANUWAVE Health has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Take a look at our analysis of SNWV’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through SANUWAVE Health regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is SANUWAVE Health expected to perform in the next 1 to 3 years based on estimates from 1 analyst?

70.9%

Forecasted annual revenue growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

SANUWAVE Health's revenue is expected to grow significantly at over 20% yearly.

Unable to determine if SANUWAVE Health is high growth as no earnings estimate data is available.

SANUWAVE Health's revenue growth is expected to exceed the United States of America market average.

Unable to compare SANUWAVE Health's earnings growth to the United States of America market average as no estimate data is available.

Unable to compare SANUWAVE Health's earnings growth to the low risk savings rate as no estimate data is available.


Earnings per Share Growth Estimates


Future Return on Equity

Unable to establish if SANUWAVE Health will efficiently use shareholders’ funds in the future without estimates of Return on Equity.


Next Steps

Past Performance

How has SANUWAVE Health performed over the past 5 years?

-12.7%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

SANUWAVE Health does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare SANUWAVE Health's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare SANUWAVE Health's 1-year growth to the US Medical Equipment industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if SANUWAVE Health has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.


Return on Assets

It is difficult to establish if SANUWAVE Health has efficiently used its assets last year compared to the US Medical Equipment industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if SANUWAVE Health improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to its liabilities exceeding its assets.


Next Steps

Financial Health

How is SANUWAVE Health's financial position?


Financial Position Analysis

SANUWAVE Health's short term (1 year) commitments are greater than its holdings of cash and other short term assets.

SANUWAVE Health's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

SANUWAVE Health has negative shareholder equity (liabilities exceed assets), this is a more serious situation compared with a high debt level.

Irrelevant to check if SANUWAVE Health's debt level has increased considering it has negative shareholder equity.


Balance Sheet

High level of physical assets or inventory.

SANUWAVE Health has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

SANUWAVE Health has less than a year of cash runway based on current free cash flow.

SANUWAVE Health has less than a year of cash runway if free cash flow continues to grow at historical rates of 14.4% each year.


Next Steps

Dividend

What is SANUWAVE Health's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate SANUWAVE Health's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate SANUWAVE Health's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as SANUWAVE Health has not reported any payouts.

Unable to verify if SANUWAVE Health's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as SANUWAVE Health has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of SANUWAVE Health's salary, the management and board of directors tenure and is there insider trading?

3.3yrs

Average management tenure


CEO

Kevin Richardson (51yo)

5.4yrs

Tenure

US$730,659

Compensation

Mr. Kevin A. Richardson, II has been the Chairman and Chief Executive Officer of SANUWAVE Health, Inc. since October 2009 and November 30, 2018 respectively. Mr. Richardson served as Active Chief Executive ...


CEO Compensation Analysis

Kevin's remuneration is higher than average for companies of similar size in United States of America.

Kevin's compensation has increased whilst company is loss making.


Management Age and Tenure

3.3yrs

Average Tenure

51yo

Average Age

The tenure for the SANUWAVE Health management team is about average.


Board Age and Tenure

3.4yrs

Average Tenure

53yo

Average Age

The tenure for the SANUWAVE Health board of directors is about average.


Insider Trading

More shares have been bought than sold by SANUWAVE Health individual insiders in the past 3 months.


Recent Insider Transactions

BuyUS$1,189,30528 Aug 19
Anthony Stolarski
EntityIndividual
Role
Member of the Board of Directors
Director
Shares10,811,864
Max PriceUS$0.11
BuyUS$612,69028 Aug 19
Kevin Richardson
EntityIndividual
Role
Chief Executive Officer
Chairman & CEO
Shares5,569,910
Max PriceUS$0.11
BuyUS$198,00025 Apr 19
Anthony Stolarski
EntityIndividual
Role
Member of the Board of Directors
Director
Shares2,475,000
Max PriceUS$0.08

Ownership Breakdown


Management Team

  • Kevin Richardson (51yo)

    Chairman & CEO

    • Tenure: 5.4yrs
    • Compensation: US$730.66k
  • Pete Stegagno (59yo)

    Chief Operating Officer

    • Tenure: 13.5yrs
    • Compensation: US$369.64k
  • Iulian Cioanta (56yo)

    Chief Science & Technology Officer

    • Tenure: 1yrs
    • Compensation: US$378.11k
  • Lisa Sundstrom (50yo)

    Chief Financial Officer

    • Tenure: 4.1yrs
    • Compensation: US$363.38k
  • André Mouton

    Vice President of International Sales & Relations

    • Tenure: 2.6yrs
  • Shri Parikh (47yo)

    President of Healthcare Division

    • Tenure: 1.3yrs
    • Compensation: US$529.50k

Board Members

  • Kevin Richardson (51yo)

    Chairman & CEO

    • Tenure: 5.4yrs
    • Compensation: US$730.66k
  • Alan Rubino (64yo)

    Director

    • Tenure: 6yrs
    • Compensation: US$112.10k
  • John Nemelka (53yo)

    Director

    • Tenure: 9.9yrs
    • Compensation: US$112.10k
  • Maj-Britt Kaltoft (55yo)

    Director

    • Tenure: 2.3yrs
    • Compensation: US$112.10k
  • Mike Stolarski (48yo)

    Director

    • Tenure: 3.4yrs
    • Compensation: US$112.10k
  • Patrick Sesto

    Member of Medical & Science Advisory Board

    • Tenure: 2.3yrs
  • Perry Mayer

    Member of Clinical Advisory Board

    • Tenure: 1.3yrs

Company Information

SANUWAVE Health, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: SANUWAVE Health, Inc.
  • Ticker: SNWV
  • Exchange: OTCPK
  • Founded: 2005
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$37.086m
  • Shares outstanding: 239.42m
  • Website: https://www.sanuwave.com

Number of Employees


Location

  • SANUWAVE Health, Inc.
  • 3360 Martin Farm Road
  • Suite 100
  • Suwanee
  • Georgia
  • 30024
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
SNWVOTCPK (Pink Sheets LLC)YesCommon StockUSUSDSep 2009

Biography

SANUWAVE Health, Inc., a shock wave technology company, focuses on the development and commercialization of noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applicatio ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/23 00:09
End of Day Share Price2019/09/20 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.